2-(2-(2,4-difluorophenyl)allyl)propane-1,3-diyl bis(2-methylpropanoate)

Catalog No. :
ACOTQR920
CAS No. :
208187-15-9
Molecular Formula :
C20H26F2O4
Molecular Weight :
368.42

IUPAC Name:2-(2-(2,4-difluorophenyl)allyl)propane-1,3-diyl bis(2-methylpropanoate)

2-(2-(2,4-difluorophenyl)allyl)propane-1,3-diyl bis(2-methylpropanoate) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-(2,4-difluorophenyl)allyl)propane-1,3-diyl bis(2-methylpropanoate)
IUPAC Name2-(2-(2,4-difluorophenyl)allyl)propane-1,3-diyl bis(2-methylpropanoate)
Molecular FormulaC20H26F2O4
Molecular Weight368.42
SMILESC=C(CC(COC(=O)C(C)C)COC(=O)C(C)C)C1=CC=C(F)C=C1F
InChI KeyYKKWXYULUZTMHQ-UHFFFAOYSA-N
SynonymPosaconazole Impurity 63;Propanoic acid, 2-methyl-, 2-[2-(2,4-difluorophenyl)-2-propenyl]-1,3-propanediyl ester (9CI);PosacozoleImpurity63;Propanoic acid, 2-methyl-, 2-[2-(2,4-difluorophenyl)-2-propenyl]-1,3-propanediyl ester
CAS No.208187-15-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACOTQR920 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRWCM710 route compound structure diagram
    ACRWCM7102065-66-9 In Stock
  4. Then
  5. ACOTQR920 route product structure diagram
    ACOTQR920208187-15-9
Inquiry

2. ACOTQR920 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOTQR920 route product structure diagram
    ACOTQR920208187-15-9
Inquiry

Comments (0)